Partneringdesk Deals and Alliances In Infectious Diseases

Report summary Partneringdesk deals and alliances in infectious diseases provides an in-depth view of over 1600 deals and alliances announced in infectious diseases between 2001 and 2006, in a clear and accessible PDF format. Reasons to purchase (USPs and key questions answered) Partneringdesk Deals and alliances in infectious diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the assessment of deal-making trends in the last five years identifying active partners tracking competitor activity benchmarking deals Partneringdesk deals and alliances in infectious diseases brings all the relevant partnering deals into one place, providing a ready reference to deal making in infectious diseases. Report scope (bullet points) The report contains: fully categorized deal overviews financial information where disclosed company profiles of the top 25 dealmakers in the report specialized indexes by company, development stage, deal type and industry sector. wider coverage of Japanese deals courtesy of JCN Forecasts, projections, market estimates This report provides a series of charts with analyses detailing market trends in infectious diseases deal making over the period of 2001 to 2006. Methodology This report is derived from data obtained from Pharmalicensing’s Partneringdesk deals and alliances database. The database is updated daily using industry sources.

Additional Information

Who should buy the report
This report is essential reading for board and executive management, and individuals in:

• business development
• licensing/partnering
• deal making
• business strategy
• marketing and promotion
• distribution and manufacturing (including contract services).

Companies analyzed/mentioned
Abbott Laboratories
Aventis
Beckman Coulter Inc
Boehringer Ingelheim GmbH
Calypte Biomedical Corp
Cangene
CEL-SCI Corp
Centers for Disease Control and Prevention
Chiron Corp
CombiMatrix
Corixa
Crucell
Gilead Sciences Inc
GlaxoSmithKline
Hemispherx BioPharma Inc
InterMune
International AIDS Vaccine Initiative
Medicines for Malaria Venture
Merck & Co Inc
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Roche
US Army Medical Research Institute of Infectious Diseases
VaxGen Inc
ViroLogic